Adicet Bio (ACET)
(Delayed Data from NSDQ)
$1.17 USD
+0.10 (9.35%)
Updated Jul 8, 2024 04:00 PM ET
After-Market: $1.20 +0.03 (2.56%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/14/24 |
---|---|
Current Quarter | -0.35 |
EPS Last Quarter | -0.35 |
Last EPS Surprise | 0.00% |
ABR | 1.50 |
Earnings ESP
|
13.67% |
---|---|
Current Year | -1.37 |
Next Year | -1.77 |
EPS (TTM) | -2.50 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | 5.00M | 15.00M | 25.00M |
# of Estimates | NA | 1 | 1 | 1 |
High Estimate | NA | 5.00M | 15.00M | 25.00M |
Low Estimate | NA | 5.00M | 15.00M | 25.00M |
Year ago Sales | 0.00M | 0.00M | 24.99M | 15.00M |
Year over Year Growth Est. | NA | NA | -39.98% | 66.67% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.35 | -0.35 | -1.37 | -1.77 |
# of Estimates | 4 | 4 | 3 | 4 |
Most Recent Consensus | -0.35 | -0.36 | -1.44 | -1.42 |
High Estimate | -0.30 | -0.27 | -1.22 | -0.89 |
Low Estimate | -0.39 | -0.41 | -1.49 | -3.33 |
Year ago EPS | -0.75 | -0.71 | -2.86 | -1.37 |
Year over Year Growth Est. | 53.33% | 50.70% | 52.10% | -29.07% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.35 | -0.35 | -1.37 | -1.77 |
7 Days Ago | -0.35 | -0.35 | -1.37 | -1.77 |
30 Days Ago | -0.35 | -0.35 | -1.37 | -1.77 |
60 Days Ago | -0.32 | -0.32 | -1.28 | -1.84 |
90 Days Ago | -0.32 | -0.32 | -1.28 | -1.84 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.30 | -0.27 | -1.22 | -0.89 |
Zacks Consensus Estimate | -0.35 | -0.35 | -1.37 | -1.77 |
Earnings ESP | 13.67% | 22.86% | 10.73% | 49.58% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.35 | -0.69 | -0.71 | -0.75 | NA |
Estimate | -0.35 | -0.72 | -0.73 | -0.68 | NA |
Difference | 0.00 | 0.03 | 0.02 | -0.07 | -0.01 |
Surprise | 0.00% | 4.17% | 2.74% | -10.29% | -0.85% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more